Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Elise Chong, MD
Patients with follicular lymphoma who relapse or don’t respond to treatment don’t have many therapeutic options, but a recently FDA-approved CAR T-cell therapy may help change that. Dr. Charles Turck is joined by Dr. Elise Chong from Penn Medicine’s Abramson Cancer Center to explore this new treatment option.
Thông Tin
- Chương trình
- Đã xuất bản04:00 UTC 30 tháng 9, 2022
- Xếp hạngSạch